Bio Green Med Solution 10% owner sells 26,051 shares at $5.50

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS) Form 4: A reporting person identified as a 10% owner reported a sale of common stock. On 10/16/2025, the holder sold 26,051 shares (transaction code S) at a price of $5.50 per share. Following this transaction, the filer beneficially owned 479,707 shares, held directly.

Insider Trade Summary

Net Seller: 26,051 shares

Net Sell 1 txn

Insider FITTERS Diversified Berhad

Role 10% Owner

Sold 26,051 shs ($143K)

Type	Security	Shares	Price	Value
Sale	Common Stock	26,051	$5.50	$143K

Holdings After Transaction: Common Stock — 479,707 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/20/2025 - 06:00 PM Learn about SEC filing dates

FAQ

What insider transaction did BGMS report on Form 4?

A 10% owner sold 26,051 shares of common stock at $5.50 on 10/16/2025.

How many BGMS shares does the insider own after the sale?

The reporting person beneficially owns 479,707 shares directly after the reported transaction.

What does the transaction code 'S' mean on the BGMS Form 4?

Code S indicates a sale of securities.

What price were the BGMS shares sold for?

The shares were sold at $5.50 per share.

What is the reporting person's relationship to BGMS?

The filer is identified as a 10% Owner.

Was the BGMS ownership held directly or indirectly?

Ownership is reported as Direct (D).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FITTERS Diversified Berhad

(Last) (First) (Middle)

NO. 1, JALAN TEMBAGA SD 5/2

BANDAR SRI DAMANSARA

(Street)

KUALA LUMPUR N8 52200

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/16/2025		S		26,051	D	$5.5	479,707	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Datuk Tan Chor How Christopher	10/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.